Roberta J Secrest Selected Research

Neoplasms (Cancer)

3/2008

Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberta J Secrest Research Topics

Disease

4	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 08/2013 - 09/2011
3	Erectile Dysfunction 08/2013 - 11/2011
3	Lower Urinary Tract Symptoms 08/2013 - 09/2011
3	Osteoporosis 03/2008 - 09/2003
3	Breast Neoplasms (Breast Cancer) 03/2008 - 01/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2016 - 08/2015
1	Neutropenia 07/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2016
1	Infections 07/2016
1	Headache (Headaches) 11/2011
1	Back Pain (Backache) 11/2011
1	Neoplasms (Cancer) 03/2008
1	Thromboembolism 12/2004
1	Postmenopausal Osteoporosis 01/2004
1	Metabolic Bone Diseases (Osteopenia) 09/2003

Drug/Important Bio-Agent (IBA)

4	Tadalafil (Cialis)FDA Link 08/2013 - 09/2011
4	Raloxifene Hydrochloride (Evista)FDA Link 03/2008 - 09/2003
3	Estrogen ReceptorsIBA 03/2008 - 01/2004
2	ixekizumabIBA 07/2016 - 08/2015
2	Etanercept (Enbrel)FDA Link 07/2016 - 08/2015
2	Interleukin-17 (Interleukin 17)IBA 07/2016 - 08/2015
1	Monoclonal AntibodiesIBA 07/2016
1	Tamsulosin (Flomax)FDA LinkGeneric 09/2011
1	MineralsIBA 03/2008
1	Estrogens (Estrogen)FDA Link 01/2004
1	Tamoxifen FDA LinkGeneric 01/2004
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2004

Therapy/Procedure

2	Therapeutics 03/2008 - 12/2004
1	Biological Therapy 08/2015